European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 278-282 , August 2010

Delay and misdiagnosis in sub-massive and non-massive acute pulmonary embolism

Received 22 February 2010 ,Revised 9 April 2010 ,Accepted 13 April 2010.

References 

  1. Alonso JL, Echegaray M, Urbieta M, Abínzano ML, García JL, González C. Acute lung embolism: a prospective study from May 1992 to May 2002. Rev Clin Esp. 2004;204:521–527
  2. Echegaray M, Alonso JL, Urbieta M, Abínzano ML, González C, Solano M. Pulmonary thromboembolism: long-term course and clinical epidemiology. An Med Interna. 2003;20:451–456
  3. Elliott CG, Goldhaber SZ, Jensen LR. Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005;128:3372–3376
  4. Ageno W, Agnelli G, Imberti D, Moia M, Palareti G, Pistelli R, et al. Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. Thromb Res. 2008;121:751–756
  5. Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest. 2010;Ahead of print Jan 15
  6. Kline JA, Hernandez J, Jones AE, Rose GA, Norton HJ. Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med. 2007;14:592–598
  7. Jiménez Castro D, Sueiro A, Díaz G, Escobar C, Garcia-Rull S, Picher J, et al. Prognostic significance of delays in diagnosis of pulmonary embolism. Thromb Res. 2007;121:153–158
  8. Ljungqvist M, Söderberg M, Mortiz P, Ahlgren A, Lärfars G. Evaluation of Wells score and repeated D-dimer in diagnosing venous thromboembolism. Eur J Intern Med. 2008;19:285–288
  9. Arnason T, Wells PS, Forster AJ. Appropriateness of diagnostic strategies for evaluating suspected venous thromboembolism. Thromb Haemost. 2007;97:195–201
  10. Kabrhel C, Camargo CA, Goldhaber SZ. Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?. Chest. 2005;127:1627–1630
  11. Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism. A meta-analysis. Circulation. 2007;116:427–433
  12. Jiménez D, Uresandi F, Otero R, Lobo JL, Monreal M, Martí D, et al. Troponin-based risk stratification of patients with acute nonmassive pulmonary embolism. Systematic review and metaanalysis. Chest. 2009;136:974–982
  13. Söhne M, ten Wolde M, Boomsma F, Reitsma JB, Douketis JD, Büllet HR. Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. J Thromb Haemost. 2006;552–556
  14. Kiely DG, Kennedy NS, Pizarda O, Batchelor SA, Strauthers AD, Lipworth BJ. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism. Respir Med. 2005;99:1286–1291
  15. ten Wolde M, Tulevsky II, Mulder JVM, Söhne M, Boomsma F, Mulder BJ, et al. Brain natriuretic peptides as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003;107:2082–2084
  16. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003;107:2545–2547
  17. Ray P, Maziere F, Medimagh S, Lefort Y, Arthaud M, Dughet A, et al. Evaluation of B-type natriuretic peptide to predict complicated pulmonary embolism in patients aged 65years and older: brief report. Am J Emerf Med. 2006;24:603–607
  18. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–1389
  19. Frémont B, Pacouret P, Jacobi D, Puglisi R, Charbonnier B, de Labriolle A. Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in patients with acute pulmonary embolism. Chest. 2008;133:358–362
  20. Stein PD, Beemath A, Matta F, Goodman LR, Weg JG, Hales CA, et al. Enlarged right ventricle without shock in acute pulmonary embolism: prognosis. Am J Med. 2008;121:34–42
  21. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep venous thrombosis. Arch Intern Med. 1997;157:2562–2568
  22. Anand SS, Bates S, Ginsberg JS, Levine M, Buller H, Prins M, et al. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times. Arch Intern Med. 1999;159:2029–2032

PII: S0953-6205(10)00066-X

doi: 10.1016/j.ejim.2010.04.005

European Journal of Internal Medicine
Volume 21, Issue 4 , Pages 278-282 , August 2010

Article Tools

* Image Usage & Resolution